| Views | |
|---|---|
| Evaluation of safety, efficacy and pharmacokinetics of Eltrombopag in patients with chronic immune thrombocytopenia: Meta-analysis of randomized controlled trials | 56 |
| November 2024 | December 2024 | January 2025 | February 2025 | March 2025 | April 2025 | May 2025 | |
|---|---|---|---|---|---|---|---|
| Evaluation of safety, efficacy and pharmacokinetics of Eltrombopag in patients with chronic immune thrombocytopenia: Meta-analysis of randomized controlled trials | 2 | 3 | 6 | 0 | 2 | 2 | 0 |
| Views | |
|---|---|
| Alkhawaldeh_Evaluation_23.pdf | 24 |
| Views | |
|---|---|
| Canada | 14 |
| United States | 12 |
| Germany | 4 |
| India | 1 |
| Russia | 1 |
| Views | |
|---|---|
| Ottawa | 14 |
| Mountain View | 3 |
| Durham | 2 |
| Sacramento | 2 |
| Baltimore | 1 |
| Dallas | 1 |
| Mumbai | 1 |
| Mytishchi | 1 |
| Washington | 1 |
| Yakima | 1 |